S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
FORGET 99% of The Stock Market (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
FORGET 99% of The Stock Market (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
FORGET 99% of The Stock Market (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Here's Bill Bonner's "4th and Final Prediction" (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
FORGET 99% of The Stock Market (Ad)pixel
NASDAQ:SMED

Sharps Compliance - SMED Stock Forecast, Price & News

$8.70
+0.03 (+0.35%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.68
$8.71
50-Day Range
$2.85
$8.70
52-Week Range
$2.83
$9.99
Volume
77,430 shs
Average Volume
234,187 shs
Market Capitalization
$169.04 million
P/E Ratio
28.06
Dividend Yield
N/A
Price Target
$6.50

Sharps Compliance MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
25.3% Downside
$6.50 Price Target
Short Interest
Healthy
2.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.32mentions of Sharps Compliance in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$640,904 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.03) to $0.08 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.70 out of 5 stars

Industrial Products Sector

170th out of 187 stocks

Sanitary Services Industry

7th out of 7 stocks

SMED stock logo

About Sharps Compliance (NASDAQ:SMED) Stock

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SMED. StockNews.com lowered shares of Sharps Compliance from a "hold" rating to a "sell" rating in a research report on Wednesday, July 13th. Lake Street Capital cut shares of Sharps Compliance from a "buy" rating to a "hold" rating in a report on Tuesday, July 12th. Barrington Research downgraded shares of Sharps Compliance from an "outperform" rating to a "market perform" rating in a research note on Tuesday, July 12th. Finally, Stifel Nicolaus cut Sharps Compliance from a "buy" rating to a "hold" rating in a research report on Wednesday, July 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Based on data from MarketBeat.com, Sharps Compliance has a consensus rating of "Hold" and a consensus price target of $6.50.

Sharps Compliance Price Performance

SMED Stock traded up $0.03 on Friday, reaching $8.70. 77,430 shares of the company's stock were exchanged, compared to its average volume of 234,187. Sharps Compliance has a twelve month low of $2.83 and a twelve month high of $9.99. The company has a quick ratio of 3.03, a current ratio of 3.50 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average of $5.72 and a 200-day moving average of $5.47. The firm has a market cap of $169.04 million, a PE ratio of 27.97 and a beta of 1.28.

Sharps Compliance (NASDAQ:SMED - Get Rating) last announced its quarterly earnings results on Wednesday, May 11th. The industrial products company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Sharps Compliance had a net margin of 7.88% and a return on equity of 5.48%. The company had revenue of $17.58 million during the quarter, compared to analysts' expectations of $16.67 million. During the same quarter in the prior year, the business earned $0.40 EPS. As a group, equities analysts predict that Sharps Compliance will post -0.03 EPS for the current fiscal year.

Insider Activity

In related news, CEO David P. Tusa sold 25,000 shares of the firm's stock in a transaction that occurred on Friday, May 27th. The stock was sold at an average price of $4.25, for a total value of $106,250.00. Following the completion of the transaction, the chief executive officer now directly owns 88,088 shares of the company's stock, valued at approximately $374,374. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Sharps Compliance news, CEO David P. Tusa sold 25,000 shares of the company's stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $4.25, for a total value of $106,250.00. Following the sale, the chief executive officer now owns 88,088 shares of the company's stock, valued at $374,374. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David P. Tusa sold 88,988 shares of the firm's stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $4.41, for a total transaction of $392,437.08. Following the transaction, the chief executive officer now directly owns 56,094 shares of the company's stock, valued at $247,374.54. The disclosure for this sale can be found here. In the last three months, insiders sold 147,294 shares of company stock worth $640,904. Company insiders own 4.80% of the company's stock.

Receive SMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sharps Compliance and its competitors with MarketBeat's FREE daily newsletter.

SMED Stock News Headlines

Why Is Sharps Compliance (SMED) Stock Up 200% Today?
Hubbell (HUBB) Q1 Earnings and Revenues Top Estimates
See More Headlines
Receive SMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sharps Compliance and its competitors with MarketBeat's FREE daily newsletter.

SMED Company Calendar

Last Earnings
10/26/2021
Today
8/13/2022
Next Earnings (Estimated)
8/17/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Sanitary services
Sub-Industry
N/A
Current Symbol
NASDAQ:SMED
Employees
190
Year Founded
1994

Price Target and Rating

Average Stock Price Forecast
$6.50
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
-25.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$12.87 million
Pretax Margin
4.55%

Debt

Sales & Book Value

Annual Sales
$76.42 million
Cash Flow
$0.74 per share
Book Value
$2.71 per share

Miscellaneous

Free Float
18,497,000
Market Cap
$169.04 million
Optionable
Optionable
Beta
1.28

Social Links















SMED Stock - Frequently Asked Questions

Should I buy or sell Sharps Compliance stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sharps Compliance in the last year. There are currently 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SMED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SMED, but not buy additional shares or sell existing shares.
View SMED analyst ratings
or view top-rated stocks.

What is Sharps Compliance's stock price forecast for 2022?

5 brokerages have issued 12-month target prices for Sharps Compliance's shares. Their SMED share price forecasts range from $6.00 to $7.00. On average, they anticipate the company's stock price to reach $6.50 in the next year. This suggests that the stock has a possible downside of 25.3%.
View analysts price targets for SMED
or view top-rated stocks among Wall Street analysts.

How have SMED shares performed in 2022?

Sharps Compliance's stock was trading at $7.13 on January 1st, 2022. Since then, SMED shares have increased by 22.0% and is now trading at $8.70.
View the best growth stocks for 2022 here
.

When is Sharps Compliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 17th 2022.
View our SMED earnings forecast
.

How were Sharps Compliance's earnings last quarter?

Sharps Compliance Corp. (NASDAQ:SMED) released its quarterly earnings results on Tuesday, October, 26th. The industrial products company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.01. The industrial products company had revenue of $13.92 million for the quarter, compared to analysts' expectations of $13.49 million. Sharps Compliance had a net margin of 7.88% and a trailing twelve-month return on equity of 5.48%. During the same period last year, the business earned ($0.02) EPS.

What is David P. Tusa's approval rating as Sharps Compliance's CEO?

41 employees have rated Sharps Compliance Chief Executive Officer David P. Tusa on Glassdoor.com. David P. Tusa has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Sharps Compliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sharps Compliance investors own include Alphabet (GOOG), Block (SQ), VBI Vaccines (VBIV), NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Visa (V), AbbVie (ABBV), Avid Technology (AVID) and Gilead Sciences (GILD).

What is Sharps Compliance's stock symbol?

Sharps Compliance trades on the NASDAQ under the ticker symbol "SMED."

Who are Sharps Compliance's major shareholders?

Sharps Compliance's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Royce & Associates LP (4.38%), Renaissance Technologies LLC (2.72%), Needham Investment Management LLC (2.02%), Sanders Morris Harris LLC (1.74%), Bard Associates Inc. (1.08%) and Perkins Capital Management Inc. (0.97%). Insiders that own company stock include David P Tusa, David P Tusa, Dennis Halligan, Diana P Diaz, Gregory C Davis, Gregory C Davis, John W Dalton and Parris H Holmes Jr.
View institutional ownership trends
.

How do I buy shares of Sharps Compliance?

Shares of SMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sharps Compliance's stock price today?

One share of SMED stock can currently be purchased for approximately $8.70.

How much money does Sharps Compliance make?

Sharps Compliance (NASDAQ:SMED) has a market capitalization of $169.04 million and generates $76.42 million in revenue each year. The industrial products company earns $12.87 million in net income (profit) each year or $0.31 on an earnings per share basis.

How many employees does Sharps Compliance have?

The company employs 190 workers across the globe.

When was Sharps Compliance founded?

Sharps Compliance was founded in 1994.

How can I contact Sharps Compliance?

Sharps Compliance's mailing address is 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054. The official website for the company is www.sharpsinc.com. The industrial products company can be reached via phone at (713) 432-0300, via email at investor@sharpsinc.com, or via fax at 713-838-0508.

This page (NASDAQ:SMED) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.